Volver a Agenda
FDA’s Biosimilars Access Plan
Speaker(s)
Leah Christl, PHD
Amgen, United States
Exec Director, Global Biosimilars Regulatory Affairs & Regulatory & R&D Policy
¿Tiene una cuenta?
Already a DIA Member? Sign in. Not a member? Join.
Iniciar sesión
Novotel London Paddington
22 oct 2018 8:00 a.m. - 23 oct 2018 3:30 p.m.
3 Kingdom Street, London, W2 6BD, United Kingdom
Biosimilars Conference
Aligning multi-stakeholder goals to work towards a sustainable future